Topics:
Lymphoma
Do you apply PET-adapted therapy (FLYER trial) and omit radiation therapy for older patients (> 60 years) with early stage, non-bulky, DLBCL?
Answer from: Medical Oncologist at Academic Institution
The data from FLYER (Poeschel et al., Lancet 2019) demonstrate that in younger patients (18-60) with low-risk, early stage DLBCL, R6CHOP4 was equivalent to RCHOPx6. Additionally, we have the data from SWOG reported by Dan Persky and colleagues that, in patients with nonbulky early stage DLBCL, those...
Sign in or Register to read more